Healthcare -
Biotechnology - NASDAQ - US
$ 1.25
-1.28 %
$ 3.96 M
Market Cap
-0.1
P/E
SONN - OPERATING INCOME
Operating Income SONN - Sonnet BioTherapeutics Holdings, Inc.
-11.8 M
LAST VALUE
36.80%
2 YEAR CAGR
-20.27%
5 YEAR CAGR
0.00%
10 YEAR CAGR